Alpine Immune Sciences, Inc. (ALPN)
NASDAQ: ALPN · IEX Real-Time Price · USD
64.55
+0.12 (0.19%)
At close: Apr 19, 2024, 4:00 PM
64.54
-0.01 (-0.02%)
After-hours: Apr 19, 2024, 6:01 PM EDT
Alpine Immune Sciences Market Cap
Alpine Immune Sciences has a market cap or net worth of $4.23 billion as of April 19, 2024. Its market cap has increased by 1,122.13% in one year.
Market Cap
4.23B
Enterprise Value
3.90B
1-Year Change
1,122.13%
Ranking
Category
Stock Price
$64.55
Market Cap Chart
Since June 17, 2015, Alpine Immune Sciences's market cap has increased from $200.10M to $4.23B, an increase of 2,014.44%. That is a compound annual growth rate of 41.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 4.22B | -0.05% |
Apr 17, 2024 | 4.23B | -0.06% |
Apr 16, 2024 | 4.23B | 0.12% |
Apr 15, 2024 | 4.22B | 0.08% |
Apr 12, 2024 | 4.22B | -0.05% |
Apr 11, 2024 | 4.22B | 36.91% |
Apr 10, 2024 | 3.08B | 20.80% |
Apr 9, 2024 | 2.55B | 1.07% |
Apr 8, 2024 | 2.53B | 10.37% |
Apr 5, 2024 | 2.29B | -1.19% |
Apr 4, 2024 | 2.32B | -7.30% |
Apr 3, 2024 | 2.50B | -2.81% |
Apr 2, 2024 | 2.57B | -2.51% |
Apr 1, 2024 | 2.64B | 1.47% |
Mar 28, 2024 | 2.60B | 2.56% |
Mar 27, 2024 | 2.53B | 3.21% |
Mar 26, 2024 | 2.45B | -0.27% |
Mar 25, 2024 | 2.46B | -4.55% |
Mar 22, 2024 | 2.58B | -5.43% |
Mar 21, 2024 | 2.73B | 3.41% |
Mar 20, 2024 | 2.64B | 13.61% |
Mar 19, 2024 | 2.32B | 12.63% |
Mar 18, 2024 | 2.06B | -2.50% |
Mar 15, 2024 | 2.11B | 1.37% |
Mar 14, 2024 | 2.09B | -1.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CRISPR Therapeutics AG | 4.72B |
Doximity | 4.70B |
BridgeBio Pharma | 4.61B |
Organon & Co. | 4.57B |
Haemonetics | 4.31B |
Lantheus Holdings | 4.21B |
Merit Medical Systems | 4.14B |
Immunovant | 4.13B |